Royal Bank of Canada »

Brainstorm Cell Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 544 0.00
2023-09-30 $0 2.0k 0.00
2023-06-30 $5.2k 2.5k 2.12
2022-12-31 $3.0k 1.5k 1.96
2022-09-30 $7.0k 1.5k 4.57
2021-06-30 $5.5k 1.9k 2.95
2021-03-31 $39k 9.4k 4.13
2020-12-31 $55k 12k 4.55
2020-09-30 $190k 11k 16.87
2020-06-30 $145k 13k 11.21
2020-03-31 $59k 13k 4.66
2019-12-31 $42k 9.8k 4.33
2019-09-30 $29k 10k 2.88
2019-03-31 $42k 9.8k 4.33
2018-12-31 $34k 9.5k 3.56
2018-09-30 $0 9.6k 0.00
2018-06-30 $37k 9.5k 3.89
2018-03-31 $30k 9.5k 3.11
2017-12-31 $18k 4.5k 4.00
2016-12-31 $6.3k 2.5k 2.50
2016-09-30 $29k 12k 2.50
2016-06-30 $29k 12k 2.50
2016-03-31 $29k 12k 2.50
2015-12-31 $20k 10k 2.00
2015-09-30 $14k 7.0k 2.00
2015-03-31 $4.1k 1.0k 4.00
2014-12-31 $4.1k 1.0k 4.00
2014-09-30 $2.0k 533 3.75